{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:37:04Z","timestamp":1759541824247},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.mehy.2006.10.059","type":"journal-article","created":{"date-parts":[[2007,1,26]],"date-time":"2007-01-26T17:44:42Z","timestamp":1169833482000},"page":"99-103","source":"Crossref","is-referenced-by-count":11,"title":["Mast cell, a promising therapeutic target in tubulointerstitial fibrosis"],"prefix":"10.1016","volume":"69","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-You","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Ming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"S1","key":"10.1016\/j.mehy.2006.10.059_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/ndt\/13.suppl_1.80","article-title":"Tubulointerstitial damage in glomerular diseases: its role in the progression of the renal damage","volume":"13","author":"D\u2019Amico","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"99","key":"10.1016\/j.mehy.2006.10.059_bib2","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1111\/j.1523-1755.2005.09915.x","article-title":"Tubulointerstitial damage and progression of renal failure","author":"Rodriguez-Iturbe","year":"2005","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.059_bib3","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1046\/j.1523-1755.2001.0590051626.x","article-title":"Role of immunocompetent cells in nonimmune renal diseases","volume":"59","author":"Rodriguez-Iturbe","year":"2001","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.059_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/1566524054553478","article-title":"Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis","volume":"5","author":"Okada","year":"2005","journal-title":"Curr Mol Med"},{"issue":"6","key":"10.1016\/j.mehy.2006.10.059_bib5","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/j.1523-1755.2004.66038.x","article-title":"CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome","volume":"66","author":"Vielhauer","year":"2004","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.059_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)63292-0","article-title":"Blockade of CCR2 ameliorates progressive fibrosis in kidney","volume":"165","author":"Kitagawa","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2006.10.059_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000046647","article-title":"Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications","volume":"21","author":"Chang","year":"2001","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.059_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1681\/ASN.V132431","article-title":"Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats","volume":"13","author":"Debelle","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.mehy.2006.10.059_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0272-6386(98)70022-8","article-title":"Tubulointerstitial mast cell infiltration in glomerulonephritis","volume":"32","author":"Hiromura","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.059_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1191\/0960327105ht502oa","article-title":"Mast cell infiltration associated with tubulointerstitial fibrosis in chronic aristolochic acid nephropathy","volume":"24","author":"Wu","year":"2005","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.mehy.2006.10.059_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/ajkd.1998.v31.pm9506682","article-title":"Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis","volume":"31","author":"Zoja","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mehy.2006.10.059_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1357-2725(98)00125-3","article-title":"Angiotensin II and extracellular matrix homeostasis","volume":"31","author":"Weber","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.mehy.2006.10.059_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.HYP.32.3.387","article-title":"Pathways for angiotensin II generation in intact human tissue evidence from comparative pharmacological interruption of the renin system","volume":"32","author":"Hollenberg","year":"1998","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.mehy.2006.10.059_bib14","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1046\/j.1523-1755.2001.0590041374.x","article-title":"Mast cell chymase expression and mast cell phenotypes in human rejected kidneys","volume":"59","author":"Yamada","year":"2001","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.mehy.2006.10.059_bib15","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1681\/ASN.V1071498","article-title":"Mast cells in rapidly progressive glomerulonephritis","volume":"10","author":"Toth","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.059_bib16","first-page":"419","article-title":"Role of mast cells in dermatofibroma: recent viewpoints into the pathogenesis","volume":"13","author":"Yamamoto","year":"2003","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.059_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11926-003-0043-3","article-title":"Mast cells in the pathogenesis of fibrosis","volume":"5","author":"Gruber","year":"2003","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.059_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:34:2:97","article-title":"Development, migration, and survival of mast cells","volume":"34","author":"Okayama","year":"2006","journal-title":"Immunol Res"},{"issue":"1\u20133","key":"10.1016\/j.mehy.2006.10.059_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejphar.2005.12.067","article-title":"Stem cell factor and its receptor c-Kit as targets for inflammatory diseases","volume":"533","author":"Reber","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2006.10.059_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0272-6386(03)00026-X","article-title":"Stem cell factor and crescentic glomerulonephritis","volume":"41","author":"El Kossi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mehy.2006.10.059_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1523-1755.2001.00783.x","article-title":"Role of mast cells in the progression of chronic glomerulonephritides","volume":"60","author":"El-Koraie","year":"2001","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.059_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s101570300005","article-title":"Mast cells and tubulointerstitial fibrosis in patients with ANCA-associated glomerulonephritis","volume":"7","author":"Otsubo","year":"2003","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.mehy.2006.10.059_bib23","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0022-5347(05)66400-2","article-title":"Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction","volume":"165","author":"Miyajima","year":"2001","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.mehy.2006.10.059_bib24","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1097\/01.ASN.0000139066.77892.04","article-title":"Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model","volume":"15","author":"Kelly","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mehy.2006.10.059_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000064071","article-title":"Tranilast slows the progression of advanced diabetic nephropathy","volume":"92","author":"Soma","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.mehy.2006.10.059_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000074845","article-title":"Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy","volume":"95","author":"Mifsud","year":"2003","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.mehy.2006.10.059_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.ki.5000189","article-title":"Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells","volume":"69","author":"Qi","year":"2006","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.059_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jdiacomp.2004.02.002","article-title":"Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes","volume":"18","author":"Jones","year":"2004","journal-title":"J Diab Comp"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.059_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1139\/y04-136","article-title":"Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors","volume":"83","author":"Doggrell","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2006.10.059_bib30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.bjp.0706209","article-title":"Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice","volume":"145","author":"Shiota","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.059_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mai.2001.113049","article-title":"Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma","volume":"107","author":"Finotto","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mehy.2006.10.059_bib32","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1172\/JCI119336","article-title":"Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems","volume":"99","author":"Finotto","year":"1997","journal-title":"J Clin Invest"},{"issue":"1\u20133","key":"10.1016\/j.mehy.2006.10.059_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejphar.2005.12.067","article-title":"Stem cell factor and its receptor c-Kit as targets for inflammatory diseases","volume":"533","author":"Reber","year":"2006","journal-title":"Eur J Pharmacol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987706008541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987706008541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T03:58:17Z","timestamp":1628395097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987706008541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0306987706008541"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2006.10.059","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}